Xenetic Biosciences XBIO Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$589.9KBeat by $110.9K
EPS-$0.45Beat by $0.19
Revenue estimate$479.0K
EPS estimate-$0.64
Next report
Aug 7, 2026 (In 1 week)Versus estimates
Revenue
Q1 2026$806.9KQ4 2025$766.3KBeat by $76.3KQ3 2025$1.0MBeat by $397.0K
Q2 2025$589.9KBeat by $110.9K
Q1 2025$593.3KBeat by $77.3KQ4 2024$648.8KDiluted EPS
Q1 2026-$0.20Q4 2025-$0.22Beat by $0.30Q3 2025-$0.33Beat by $0.16
Q2 2025-$0.45Beat by $0.19
Q1 2025-$0.59Beat by $0.13Q4 2024-$0.68Ask the moment Xenetic Biosciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Xenetic Biosciences report Q2 2025 earnings?
- Xenetic Biosciences (XBIO) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Xenetic Biosciences's Q2 2025 revenue and EPS?
- Xenetic Biosciences reported revenue of $589.9K and eps of $-0.45 for Q2 2025.
- Did Xenetic Biosciences beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $479.0K by $110.9K. EPS beat the consensus estimate of $-0.64 by $0.19.
- How did Xenetic Biosciences's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 18.8% from $726.4K a year earlier and eps grew 45.8% from $-0.83.
- Where can I find Xenetic Biosciences's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-005983) directly on SEC EDGAR. The filing index links above go to sec.gov.